An open-label, multicenter study of ombitasvir/paritaprevir/ ritonavir and dasabuvir with or without ribavirin in us veterans with genotype 1 chronic hepatitis c infection: Efficacy and safety results of TOPAZ-VA

Authors
Category Primary study
JournalHepatology
Year 2016
This article has no abstract
Epistemonikos ID: cb7e2f7a271779e649b3fe508f1c10f510e278c2
First added on: Feb 08, 2025